Correlation Between Satcom Systems and Purple Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Satcom Systems and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Satcom Systems and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Satcom Systems and Purple Biotech, you can compare the effects of market volatilities on Satcom Systems and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Satcom Systems with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Satcom Systems and Purple Biotech.

Diversification Opportunities for Satcom Systems and Purple Biotech

-0.8
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Satcom and Purple is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Satcom Systems and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and Satcom Systems is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Satcom Systems are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of Satcom Systems i.e., Satcom Systems and Purple Biotech go up and down completely randomly.

Pair Corralation between Satcom Systems and Purple Biotech

Assuming the 90 days trading horizon Satcom Systems is expected to under-perform the Purple Biotech. But the stock apears to be less risky and, when comparing its historical volatility, Satcom Systems is 5.21 times less risky than Purple Biotech. The stock trades about -0.01 of its potential returns per unit of risk. The Purple Biotech is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  620.00  in Purple Biotech on September 1, 2024 and sell it today you would earn a total of  60.00  from holding Purple Biotech or generate 9.68% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Satcom Systems  vs.  Purple Biotech

 Performance 
       Timeline  
Satcom Systems 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Satcom Systems are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Satcom Systems sustained solid returns over the last few months and may actually be approaching a breakup point.
Purple Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Purple Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Satcom Systems and Purple Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Satcom Systems and Purple Biotech

The main advantage of trading using opposite Satcom Systems and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Satcom Systems position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.
The idea behind Satcom Systems and Purple Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Valuation
Check real value of public entities based on technical and fundamental data